How Long Does It Take to See the Effects of Testosterone Injections?

Some effects of testosterone injections begin within days, while others take months or even years to fully develop. A large review of the clinical literature mapped out specific timelines: sexual interest typically picks up around three weeks in, mood improvements follow within three to six weeks, and body composition changes show up after roughly three to four months. But maximum effects on things like bone density, metabolic health, and red blood cell production can take one to three years to plateau.¹ The experience is less like flipping a switch and more like a cascade of overlapping biological processes, each running on its own clock.

Sexual Interest and Function

For many men starting testosterone therapy, an increase in sex drive is the earliest noticeable change. Research consistently places the initial uptick in sexual interest at about three weeks, with a plateau around six weeks. After that point, further improvement in libido from the testosterone itself is unlikely. Erectile and ejaculatory function, however, follows a slower curve and can take up to six months to reach full benefit.¹

A placebo-controlled trial in men with type 2 diabetes found that all measured domains of sexual function improved by 30 weeks of treatment, with some benefit appearing as early as six weeks.² If you are starting testosterone and hoping for improvements in sexual function, six weeks is a reasonable checkpoint for libido, but patience through the three-to-six-month window matters for erections and overall satisfaction.

Mood, Energy, and Quality of Life

Improvements in general sense of well-being tend to show up within three to four weeks. Effects on depressed mood specifically become measurable in the three-to-six-week range, but they keep deepening over a longer period, with maximum benefit arriving somewhere between four and seven months.¹

In a small study of hypogonadal men whose depression had not responded to standard antidepressant medication, adding testosterone led to a rapid and dramatic improvement in depression scores. By week two, average depression ratings had already dropped sharply, and by week eight, scores had fallen from a range indicating moderate depression to near-normal levels.³ That speed is striking, though the study was small and uncontrolled, so it represents a best-case scenario rather than a guarantee. The broader pattern across research is that mood gets noticeably better within a month, and the gains accumulate over several more months.

Muscle Mass and Strength

Body composition changes are among the most anticipated effects, and they are also among the slower ones. The first measurable shifts in lean mass and muscle strength generally appear around 12 to 16 weeks. These changes continue building over six to twelve months, and marginal improvements can keep trickling in over years.¹

A landmark trial published in the New England Journal of Medicine demonstrated the direct muscle-building effects of testosterone even without exercise. Men who received high-dose testosterone injections for ten weeks gained measurable arm and leg muscle size and increased their bench-press and squat strength compared to placebo. Men who combined testosterone with exercise gained the most, with over six kilograms of added fat-free mass.⁴ That trial used doses well above what a doctor would prescribe for hormone replacement, but it illustrates an important point: testosterone builds muscle on its own, and exercise amplifies the effect. At therapeutic doses, expect visible strength and muscle changes to become apparent around the three-to-four-month mark.

Fat Loss and Weight Changes

Testosterone therapy tends to reduce fat mass, especially visceral fat around the midsection. Unlike the relatively quick onset of mood effects, meaningful fat loss is gradual and cumulative. In one registry study tracking hypogonadal men for up to five years, body weight dropped steadily each year, with average weight loss reaching about three percent after one year, roughly six percent after two years, and continuing to over ten percent after five years.⁵ Waist circumference shrank alongside body weight, suggesting the losses were heavily concentrated in abdominal fat.

A longer observational study followed obese hypogonadal men for up to eight years on testosterone injections. Men with the highest starting weight lost the most in absolute terms, with reductions of roughly 17 to 30 kilograms depending on their obesity class.⁶ These are observational data, not controlled experiments, so lifestyle changes during the study period likely contributed. Still, the pattern is clear: testosterone therapy supports ongoing fat loss in men who start with low levels, and the process does not peak in the first year. It keeps going.

Blood Sugar, Cholesterol, and Metabolic Health

Insulin sensitivity may begin improving within days of the first injection, but measurable changes in blood sugar control take longer. In hypogonadal men with type 2 diabetes, testosterone therapy reduced a standard measure of insulin resistance and lowered both fasting blood glucose and long-term blood sugar markers. Total cholesterol also dropped.⁷ Lipid changes generally start showing up around four weeks, with full effects on cholesterol and blood sugar taking anywhere from three to twelve months to stabilize.¹

One thing to keep in mind: testosterone lowers both total cholesterol and HDL cholesterol, the type sometimes called “good” cholesterol. A randomized trial in older men found that testosterone gel for a year produced a modest drop in total cholesterol compared to placebo but also reduced HDL. The clinical significance of a small HDL reduction in this context is not settled, but it is worth discussing with your doctor if you have existing cardiovascular risk factors.

Bone Density

Bones respond to testosterone, but they are the slowest tissue to show it. Detectable increases in bone mineral density first appear around six months and continue building for at least three years.¹ The biggest jump tends to happen during the first year, especially in men who have never been treated before.⁸ This is one of those effects that you will never feel directly, but for men with established low bone density or osteoporosis risk, it is one of the most important long-term benefits of treatment.

Skin and Hair Changes

Acne is among the more common early side effects. Research in transgender men starting testosterone found that acne severity increased during the first year and peaked around six months.⁹ A broader scoping review confirmed that skin-related side effects typically emerge within the first three to twelve months, though they were generally mild and rarely serious enough to stop treatment.¹⁰

Hair loss follows a different trajectory. In that same study of transgender men, only one participant developed noticeable thinning in the first year, but after long-term therapy, about a third had mild frontal-temple hair loss and roughly another third had moderate to severe male-pattern balding.⁹ If you are genetically predisposed to hair loss, testosterone therapy will likely accelerate it, but probably not in the first several months. Increased body and facial hair growth also develops gradually over the first year or two.

Red Blood Cell Production

Testosterone stimulates the production of red blood cells. This effect becomes evident around three months and peaks at nine to twelve months.¹ For men with mild anemia related to low testosterone, this can be a genuine benefit. But it also means that hemoglobin and hematocrit levels need monitoring, because an excessive rise in red blood cell count thickens the blood and increases the risk of clots. Most prescribing guidelines recommend blood work at baseline, around three months, and periodically after that to watch for this.

Prostate Markers

One of the most closely monitored aspects of testosterone therapy is its effect on the prostate. PSA, the blood marker doctors use to screen for prostate problems, rises modestly with testosterone treatment. In a controlled trial of older hypogonadal men, testosterone therapy raised PSA by about 0.47 ng/mL on average over 12 months, compared to virtually no change with placebo. About two percent of men treated with testosterone reached an absolute PSA above 4.0 ng/mL, versus less than one percent on placebo.¹¹

In men who start out with very low testosterone, the PSA rise can be more pronounced. A study of severely hypogonadal men found that median PSA roughly tripled from baseline to the six-to-eighteen-month period, and about 13 percent crossed the 4.0 ng/mL threshold during that window.¹² By contrast, when researchers gave exogenous testosterone to healthy young men, no significant changes in prostate volume or PSA levels occurred at any dose.¹³ The takeaway is that the prostate response depends heavily on your starting testosterone level and age. Most PSA changes plateau by 12 months, and any further rise after that point is more likely related to aging than to continued therapy.¹

Sleep and Breathing

Testosterone’s relationship with sleep-disordered breathing has generated a lot of concern, and the picture is more nuanced than the standard warnings suggest. A randomized trial in obese men with severe obstructive sleep apnea found that testosterone therapy worsened overnight oxygen levels at seven weeks, but that effect was no longer significant at 18 weeks.¹⁴ A review of the evidence described this as a time-limited effect, suggesting that the body may adapt after the initial weeks of treatment.¹⁵

That said, high-dose testosterone can disrupt sleep more clearly. A crossover study in older men who received large doses of testosterone esters found that total sleep time dropped by about an hour and measures of sleep-disordered breathing increased.¹⁶ If you have existing sleep apnea or are at high risk for it, especially if you are overweight, it is worth monitoring symptoms closely during the first couple of months and telling your doctor if snoring or daytime sleepiness worsens.

Blood Pressure and the Heart

Testosterone acts as a rapid vasodilator, meaning it relaxes blood vessels and can reduce overall vascular resistance shortly after administration.¹⁷ Despite this mechanism, controlled studies looking at whether testosterone injections change blood pressure readings have found no significant effect. One study that gave intravenous testosterone to achieve both normal and above-normal blood levels found no meaningful changes in systolic or diastolic blood pressure, or in any standard heart rhythm measurements.¹⁸ So while testosterone does directly affect blood vessels, this does not translate into noticeable swings in blood pressure for most people.

Fertility Suppression and Recovery

This is the timeline that catches many men off guard. Testosterone injections suppress the signals that tell the testes to produce sperm. If you are considering having children, this is not a side effect that reverses itself as soon as you feel like it.

After stopping two years of injectable testosterone undecanoate, full recovery of reproductive hormones is slow and progressive, potentially taking over 15 months from the last injection to be complete.¹⁹ Even with medications like hCG that are specifically designed to help restore sperm production, recovery is not guaranteed. A study of men who used testosterone and then stopped found that about 70 percent achieved a usable sperm count after hCG therapy. Both age and how long a man had been on testosterone affected the recovery timeline, with older men and longer users taking more time to recover.²⁰

The problem extends further for men who used testosterone at high doses without medical supervision. Research on former users of anabolic steroids found that a substantial proportion still had suppressed testosterone levels and symptoms of hypogonadism years after quitting.²¹ This underscores the difference between medically supervised hormone replacement and unsupervised use: the dose, duration, and whether fertility preservation strategies are built into the treatment plan all matter enormously.

Why Your Timeline May Differ

The timelines above are averages drawn from clinical studies, and individual variation is considerable. One reason is genetics. The androgen receptor, which is how your cells actually respond to testosterone, has a variable region that differs in length from person to person. Research has shown that the length of this region independently affects how metabolic markers like fasting insulin and triglycerides respond to testosterone treatment.²² In practical terms, two men on identical doses can have meaningfully different responses simply because of inherited differences in how sensitive their tissues are to the hormone.

The route of delivery also changes the pharmacokinetics, though perhaps not as dramatically as you might expect. A study comparing subcutaneous to intramuscular injection of testosterone undecanoate found that subcutaneous injection produced a later peak but ultimately delivered comparable overall testosterone exposure.²³ Peak levels came at about eight days after subcutaneous injection versus about three days for intramuscular, but the total amount of testosterone absorbed and the downstream hormone levels were not significantly different. Gels, patches, and pellets each have their own absorption profiles, which can shift the timing of when you feel the first effects, but the biological endpoints you eventually reach tend to converge once levels are stable in the normal range.

Your starting testosterone level matters too. Men who begin treatment from very low levels often notice the most dramatic early changes, particularly in mood and energy, because the absolute shift is larger. Baseline body composition, age, presence of other conditions like diabetes or obesity, and whether you exercise regularly all shape how quickly and how completely the benefits manifest. None of this means the expected timelines are wrong, just that they describe the center of a distribution, and your experience may sit toward the faster or slower end.

What a Realistic First Year Looks Like

If you distill the research into a practical calendar, the first year of testosterone therapy unfolds roughly like this:

Weeks 1 to 3: Possible early uptick in energy and general well-being. Insulin sensitivity may begin improving at the cellular level, though you would not notice this.
Weeks 3 to 6: Increased sex drive typically becomes noticeable. Mood improvements start to take shape. Quality of life ratings begin climbing.
Months 2 to 4: Lipid levels start shifting. Inflammatory markers may decrease. Depressive symptoms continue improving. First measurable changes in lean mass and fat mass begin, though they are unlikely to be visible in the mirror yet.
Months 4 to 6: Erectile function continues improving. Acne, if it develops, is likely peaking. Muscle and strength gains become more noticeable, especially if you are training. Red blood cell counts are clearly rising and should be checked.
Months 6 to 12: Bone density improvements become detectable. Fat loss continues. PSA changes are typically plateauing. Muscle and metabolic effects approach their near-maximum for this first phase. A blood panel at this point is the most informative single checkpoint for evaluating how therapy is going.

After the first year, most of the rapid changes have occurred, but weight loss, bone strengthening, and subtle body composition shifts can continue well beyond that mark. Research tracking men for five to eight years on therapy has documented ongoing progressive fat loss and waist circumference reduction year after year.⁵ The takeaway is that testosterone therapy is not a short-term intervention that reaches a fixed state. It is an ongoing treatment with an ongoing biological trajectory, and some of the most meaningful benefits are the ones you have to be patient enough to wait for.

1
PubMed Central. Onset of effects of testosterone treatment and time span until maximum effects are achieved
2
The Journal of Sexual Medicine. Testosterone Replacement Therapy with Long‒Acting Testosterone Undecanoate Improves Sexual Function and Quality‒of‒Life Parameters vs. Placebo in a Population of Men with Type 2 Diabetes
3
PubMed. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression
4
PubMed. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
5
PubMed Central. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
6
International Journal of Obesity. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies
7
PubMed. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
8
The Journal of Clinical Endocrinology & Metabolism. Long-Term Effect of Testosterone Therapy on Bone Mineral Density in Hypogonadal Men
9
The Journal of Sexual Medicine. Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men
10
Sexual Medicine Reviews. Dermatological adverse effects of testosterone replacement therapy: a scoping review of the literature
11
PubMed Central. Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial
12
Journal of the Endocrine Society. Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
13
PubMed. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men
14
PubMed. Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial
15
Sexual Medicine Reviews. Obstructive Sleep Apnea and Testosterone Therapy
16
The Journal of Clinical Endocrinology & Metabolism. The Short-Term Effects of High-Dose Testosterone on Sleep, Breathing, and Function in Older Men
17
PubMed Central. Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system
18
PubMed. The effect of pharmacokinetically guided acute intravenous testosterone administration on electrocardiographic and blood pressure variables
19
European Journal of Endocrinology. Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections
20
PubMed Central. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy
21
PLoS ONE. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study
22
European Journal of Endocrinology. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes
23
PubMed Central. Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate